The Effects of Vitamin D on All-cause Mortality in Different Diseases: an Evidence-map and Umbrella Review of 116 Randomized Controlled Trials
Overview
Affiliations
Purpose: To conduct a solid evidence by synthesizing meta-analyses and updated RCTs about the effects of vitamin D on all-cause mortality in different health conditions.
Methods: Data sources: Pubmed, Embase, Web of Science, the Cochrane Library, Google Scholar from inception until 25th April, 2022. Study selection: English-language, meta-analyses and updated RCTs assessing the relationships between vitamin D and all-cause mortality. Data synthesis: Information of study characteristics, mortality, supplementation were extracted, estimating with fixed-effects model. A Measurement Tool to Assess Systematic Reviews, Grading of Recommendations Assessment, Development and Evaluation, and funnel plot was used to assess risk of bias. Main outcomes: All-cause mortality, cancer mortality, cardiovascular disease mortality.
Results: In total of 27 meta-analyses and 19 updated RCTs were selected, with a total of 116 RCTs and 149, 865 participants. Evidence confirms that vitamin D reduces respiratory cancer mortality (RR, 0.56 [95%CI, 0.33 to 0.96]). All-cause mortality is decreased in patients with COVID-19 (RR, 0.54[95%CI, 0.33 to 0.88]) and liver diseases (RR, 0.64 [95%CI, 0.50 to 0.81]), especially in liver cirrhosis (RR, 0.63 [95%CI, 0.50 to 0.81]). As for other health conditions, such as the general health, chronic kidney disease, critical illness, cardiovascular diseases, musculoskeletal diseases, sepsis, type 2 diabetes, no significant association was found between vitamin D and all-cause mortality.
Conclusions: Vitamin D may reduce respiratory cancer mortality in respiratory cancer patients and all-cause mortality in COVID-19 and liver disorders' patients. No benefits showed in all-cause mortality after vitamin D intervention among other health conditions. The hypothesis of reduced mortality with vitamin D still requires exploration.
Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=252921, identifier: CRD42021252921.
Cipriani C, Carilli M, Rizzo M, Miele M, Sinibaldi-Vallebona P, Matteucci C Antibiotics (Basel). 2025; 14(2).
PMID: 40001388 PMC: 11851568. DOI: 10.3390/antibiotics14020144.
Li C, Zhao K, Ren Q, Chen L, Zhang Y, Wang G Front Cell Infect Microbiol. 2025; 14:1485554.
PMID: 39902186 PMC: 11788162. DOI: 10.3389/fcimb.2024.1485554.
Chen M, Cheng L, Yang S, Zhang Y BMC Geriatr. 2025; 25(1):38.
PMID: 39819506 PMC: 11740327. DOI: 10.1186/s12877-025-05687-1.
Vitamin D Supplementation in Critically Ill-Narrative Review.
Saric L, Domazet Bugarin J, Dosenovic S Nutrients. 2025; 17(1.
PMID: 39796590 PMC: 11723408. DOI: 10.3390/nu17010156.
Wimalawansa S, Weiss S, Hollis B Nutrients. 2024; 16(22).
PMID: 39599755 PMC: 11597479. DOI: 10.3390/nu16223969.